Who Buys Mesalamine from India — 214 Importers Behind a $1.3B Market
India's mesalamine import market is served by 214 active buyers who collectively imported $1.3B across 3,779 shipments. EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) leads with a 81.0% market share, followed by SUN PHARMACEUTICAL INDUSTRIES, INC. and NORTHSTAR DISTRIBUTION CENTER 8912. The top 5 buyers together control 94.7% of total import value, reflecting a concentrated buyer landscape.
Top Mesalamine Importers — Ranked by Import Value
EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) is the leading mesalamine importer from India, holding a 81.0% share of the $1.3B market across 3,779 shipments from 214 buyers. The top 5 buyers — EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), SUN PHARMACEUTICAL INDUSTRIES, INC. (UNITED STATES), NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES), SUN PHARMACEUTICAL INDUSTRIES INC (UNITED STATES), EVERSANA LIFE SCIENCE SERVICES, (UNITED STATES) — collectively control 94.7% of total import value.
Top Mesalamine Buyers & Importers
Ranked by import value · 214 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICESUNITED STATES MESALAMINE DELAYED RELEASE TABLETS 1.2 GM | $1.1B | 5 | 81.0% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES, INC.UNITED STATES MESALAMINE DELAYED RELEASE TABLETS 1.2 GMMESALAMINE DELAYED RELEASE TABLETS USP 1 | $148.6M | 5 | 11.3% |
| 3 | NORTHSTAR DISTRIBUTION CENTER 8912UNITED STATES MESALAMINE DELAYED RELEASE TABLETS 1.2 GM | $13.1M | 5 | 1.0% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES INCUNITED STATES MESALAMINE DELAYED RELEASE TABLETS 1.2 GMMESALAMINE DELAYED RELEASE TABLETS USP 1 | $11.5M | 5 | 0.9% |
| 5 | EVERSANA LIFE SCIENCE SERVICES,UNITED STATES MESALAMINE DELAYED RELEASE TABLETS 1.2 GM | $8.5M | 5 | 0.6% |
| 6 | SUN PHARMACEUTICAL INDUSTRIES,INC.UNITED STATES MESALAMINE DELAYED RELEASE TABLETS 1.2 GMMESALAMINE DELAYED RELEASE TABLETS USP 1 | $6.5M | 5 | 0.5% |
| 7 | XXN PXXRMAXXUTIXXL IXXUSTXXES XXCUNITED STATES MESALAMINE DELAYED RELEASE TABLETS 1.2 GM | $4.0M | 5 | 0.3% |
| 8 | AO RANBAXYRUSSIA MESACOL TAB 400MG (MESALAMINE TABLETS 40MESACOL 400 TABS CONTAINS MESALAMINE PACK : 10S STRIPMESACOL 400 TABS CONTAINS MESALAMINE TA | $2.9M | 5 | 0.2% |
| 9 | NORTHSTAR DISTRIBUTION CENTERUNITED STATES MESALAMINE DELAYED RELEASE TABLETS 1.2 GM | $2.2M | 5 | 0.2% |
| 10 | AO "RANBAXY"RUSSIA MESACOL TAB 400MG (MESALAMINE TABLETS 40MESACOL 400 TABS CONTAINS MESALAMINE PACK : 10S STRIPMESACOL 400 TABS CONTAINS MESALAMINE TA | $2.2M | 5 | 0.2% |
| 11 | ASCEND LABORATORIES,LLCUNITED STATES MESALAMINE DELAYED RELEASE TABLETS 1.2 GM | $1.8M | 5 | 0.1% |
| 12 | SUN PHARMACEUTICAL INDUSTRIES,INCUNITED STATES MESALAMINE DELAYED RELEASE TABLETS 1.2 GMMESALAMINE DELAYED RELEASE TABLETS USP 1 | $1.7M | 5 | 0.1% |
| 13 | ASCEND LABORATORIES LLCUNITED STATES MESALAMINE DELAYED RELEASE TABLETS 1.2 GM | $1.5M | 5 | 0.1% |
| 14 | SUN PHARMA ANZ PTY LIMITEDAUSTRALIA MESALAMINE DELAYED RELEASE TABLETS 1.2 GMMESALAMINE DELAYED RELEASE TABLETS USP 1 | $1.3M | 5 | 0.1% |
| 15 | SUN PHARMACEUTICAL INDUSTRIES INC.UNITED STATES MESALAMINE DELAYED RELEASE TABLETS 1.2 GMMESALAMINE DELAYED RELEASE TABLETS USP 1 | $1.3M | 5 | 0.1% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Mesalamine — and from which countries?
Flow of Mesalamine exports from India: each country's share and the named importers behind the numbers
Mesalamine — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $1.3B through 563 shipments. This represents a market share of 98.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• EVERSANA LIFE SCIENCE SERVICES - $1.1B (82.1% of country's total business)
• SUN PHARMACEUTICAL INDUSTRIES, INC. - $148.6M (11.4% of country's total business)
• NORTHSTAR DISTRIBUTION CENTER 8912 - $13.1M (1.0% of country's total business)
• SUN PHARMACEUTICAL INDUSTRIES INC - $11.5M (0.9% of country's total business)
• EVERSANA LIFE SCIENCE SERVICES, - $8.5M (0.7% of country's total business)
• Rest of United States's importers - $51.4M (3.9% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $2.3M, indicating premium pricing strategy compared to the market average of $349.1K.
United States is a key market for Mesalamine imports, representing 98.6% of total trade value.
2Russia
Russia emerges as the second largest importing country, achieving a total trade value of $5.3M through 36 shipments. This represents a market share of 0.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Russia has a diverse importer base, with their top importers including:
• AO RANBAXY - $2.9M (55.5% of country's total business)
• AO "RANBAXY" - $2.2M (40.8% of country's total business)
Key Insight: Russia demonstrates strong market positioning with an average shipment value of $146.9K, indicating competitive pricing strategy compared to the market average of $349.1K.
Russia is a key market for Mesalamine imports, representing 0.4% of total trade value.
3Algeria
Algeria emerges as the third largest importing country, achieving a total trade value of $4.2M through 0 shipments. This represents a market share of 0.3% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Algeria demonstrates strong market positioning with an average shipment value of $4.2M, indicating premium pricing strategy compared to the market average of $349.1K.
Algeria is a key market for Mesalamine imports, representing 0.3% of total trade value.
4Australia
Australia emerges as the fourth largest importing country, achieving a total trade value of $2.3M through 11 shipments. This represents a market share of 0.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• SUN PHARMA ANZ PTY LIMITED - $1.3M (54.9% of country's total business)
• SUN PHARMA ANZ PTY LTD - $1.1M (45.1% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $211.4K, indicating competitive pricing strategy compared to the market average of $349.1K.
Australia is a key market for Mesalamine imports, representing 0.2% of total trade value.
5Mexico
Mexico emerges as the fifth largest importing country, achieving a total trade value of $1.4M through 0 shipments. This represents a market share of 0.1% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Mexico demonstrates strong market positioning with an average shipment value of $1.4M, indicating premium pricing strategy compared to the market average of $349.1K.
Mexico is a key market for Mesalamine imports, representing 0.1% of total trade value.
Buyer Segment Analysis
TransData Nexus Mesalamine buyer market intelligence
1Buyer Segment Analysis
The 214 buyers of Mesalamine from India can be categorized into the following segments:
1. Distributors: Entities that purchase Mesalamine in bulk to supply to various healthcare providers.
2. Pharmaceutical Companies: Manufacturers that procure Mesalamine for formulation into finished products.
3. Re-exporters: Companies that import Mesalamine for the purpose of exporting to other markets.
The repeat buyer rate of 64.5% indicates a strong reliance on consistent suppliers, highlighting the importance of maintaining quality and reliability in the supply chain.
Country-Specific Import Regulations
TransData Nexus Mesalamine buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Mesalamine are as follows:
1. United States
2. Russia
3. Algeria
4. Australia
5. Mexico
Demand Drivers & Market Opportunity
TransData Nexus Mesalamine buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Mesalamine in importing countries is driven by several factors:
1. Disease Prevalence: Mesalamine is primarily used to treat inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn's disease. The prevalence of IBD has been increasing globally, contributing to higher demand for Mesalamine.
2. Government Healthcare Programs: Many countries have implemented healthcare programs aimed at improving access to essential medicines. For instance, the inclusion of Mesalamine in national formularies ensures its availability to patients through public healthcare systems.
3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines, including Mesalamine, to meet the needs of the population.
4. WHO Essential Medicines List Procurement: The World Health Organization's Essential Medicines List guides countries in selecting medicines that should be available in their healthcare systems. While Mesalamine is not listed, its therapeutic alternatives are, influencing procurement decisions.
5. Tender-Based Purchasing: Many countries utilize tender systems for procuring medicines, ensuring competitive pricing and consistent supply. For example, Sri Lanka's State Pharmaceuticals Corporation issued a tender for 420,000 tablets of Mesalamine 400mg, closing on March 31, 2026.
The presence of 214 buyers across 51 countries indicates a broad and growing market for Mesalamine, presenting significant opportunities for suppliers to meet the increasing global demand.
Common Questions — Mesalamine Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest mesalamine buyer importing from India?
Based on import volume and value, EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) leads with $1.1B in imports and a 81.0% market share — the highest of any single mesalamine importer. SUN PHARMACEUTICAL INDUSTRIES, INC. (UNITED STATES) and NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES) are the next largest buyers.
QHow many companies buy mesalamine from India?
There are 214 active mesalamine buyers importing from India, with a combined market of $1.3B across 3,779 shipments to 51 countries. The top 5 buyers hold 94.7% of total import value, while the remaining 209 buyers handle the other 5.3%.
QWhich countries import the most mesalamine from India?
The top importing countries for mesalamine from India are United States (98.6%), Russia (0.4%), Algeria (0.3%), Australia (0.2%), Mexico (0.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of mesalamine, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for mesalamine from India?
The average import transaction value for mesalamine from India is $349.1K, with an average unit price of $13.15 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Mesalamine buyer market intelligence
1Buyer Segment Analysis
The 214 buyers of Mesalamine from India can be categorized into the following segments:
1. Distributors: Entities that purchase Mesalamine in bulk to supply to various healthcare providers.
2. Pharmaceutical Companies: Manufacturers that procure Mesalamine for formulation into finished products.
3. Re-exporters: Companies that import Mesalamine for the purpose of exporting to other markets.
The repeat buyer rate of 64.5% indicates a strong reliance on consistent suppliers, highlighting the importance of maintaining quality and reliability in the supply chain.
Country-Specific Import Regulations
TransData Nexus Mesalamine buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Mesalamine are as follows:
1. United States
2. Russia
3. Algeria
4. Australia
5. Mexico
Demand Drivers & Market Opportunity
TransData Nexus Mesalamine buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Mesalamine in importing countries is driven by several factors:
1. Disease Prevalence: Mesalamine is primarily used to treat inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn's disease. The prevalence of IBD has been increasing globally, contributing to higher demand for Mesalamine.
2. Government Healthcare Programs: Many countries have implemented healthcare programs aimed at improving access to essential medicines. For instance, the inclusion of Mesalamine in national formularies ensures its availability to patients through public healthcare systems.
3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines, including Mesalamine, to meet the needs of the population.
4. WHO Essential Medicines List Procurement: The World Health Organization's Essential Medicines List guides countries in selecting medicines that should be available in their healthcare systems. While Mesalamine is not listed, its therapeutic alternatives are, influencing procurement decisions.
5. Tender-Based Purchasing: Many countries utilize tender systems for procuring medicines, ensuring competitive pricing and consistent supply. For example, Sri Lanka's State Pharmaceuticals Corporation issued a tender for 420,000 tablets of Mesalamine 400mg, closing on March 31, 2026.
The presence of 214 buyers across 51 countries indicates a broad and growing market for Mesalamine, presenting significant opportunities for suppliers to meet the increasing global demand.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 214 global importers of Mesalamine identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 3,779 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 51 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,779 Verified Shipments
214 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists